Refractory depression - Open Access .click

Results 1 to 10 of about 52,949 (159)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression [PDF]

Frontiers in Psychiatry, 2021
Objectives: To first explore the role of plasma vascular endothelial growth factor (VEGF) concentrations in ketamine's antianhedonic effects, focusing on Chinese patients with treatment-refractory depression (TRD).Methods: Seventy-eight patients with ...
Wei Zheng +9 more
doaj +2 more sources

Radically open dialectical behaviour therapy for refractory depression: the RefraMED RCT

Efficacy and Mechanism Evaluation, 2018
Background: About one-third of patients who are depressed do not respond to antidepressant medication (ADM) and traditional psychotherapy shows limited benefits.
Thomas R Lynch +15 more
doaj +2 more sources

Successful Treatment of Refractory Cancer Pain and Depression with Continuous Intrathecal Administration of Dexmedetomidine and Morphine: A Case Report

Pain and Therapy, 2020
Patients who have refractory cancer pain suffer both physically and psychologically. Cancer pain management has improved over the past few decades. However, the treatment of refractory cancer pain is still challenging all over the world.
Ge Huang +4 more
doaj +2 more sources

Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression [PDF]

Frontiers in Psychology, 2018
Three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS) has yielded one clear treatment indication in psychiatry for major depression disorder (MDD).
Chris Baeken, Chris Baeken, Chris Baeken
doaj +2 more sources

Depression and Somatization in Refractory Lateral Epicondylitis

The Turkish Journal of Gastroenterology, 2019
Objectives: This study aims to present two major psychological factors, namely depression and somatization, which may occur with high probability in patients with refractory lateral epicondylitis (LE). Patients and methods: This cross-sectional study
Eda GÜRÇAY +5 more
doaj +4 more sources

Intravenous ketamine in refractory depression

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
Shivang Gandhi +2 more
doaj +2 more sources

Intranasal esketamine for ECT-refractory bipolar depression: a case report [PDF]

Frontiers in Psychiatry
This is a case report of a 52 year old female with ECT-refractory bipolar depression who was treated with esketamine nasal spray, leading to a noticeable improvement in her depressive symptoms.
Muhammad Abbas, Bruno Kallas, Max Garris
doaj +2 more sources

Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in mice

Frontiers in Pharmacology, 2022
Clinical and preclinical studies show evidence that chronic stress or nutritional deficits in dietary zinc (Zn) intake may be risk factors for developing major depressive disorder (MDD).
Bartłomiej Pochwat +14 more
doaj +1 more source

Effects of ozone therapy on anxiety and depression in patients with refractory symptoms of severe diseases: a pilot study

Frontiers in Psychology, 2023
BackgroundPatients with refractory symptoms of severe diseases frequently experience anxiety, depression, and an altered health-related quality of life (HRQOL).
Bernardino Clavo +31 more
doaj +1 more source

Deep Brain Stimulation for the Treatment of Resistant Depression: Systematic Review of the Literature

Brazilian Neurosurgery, 2019
Depression is the leading cause of disability worldwide, and it is related to high suicide rates. Furthermore, a great number of patients do not respond to any of the available treatments.
Ícaro Elias Gualberto Santos Julião +2 more
doaj +1 more source

humans
3. good health
depressive disorder

antidepressive agents
depression
drug therapy, combination

female
male
adult